Search
Bavarian Award ‘m4’ honours the TherVacB innovative therapeutic vaccine as a promising solution to the global health challenge of chronic hepatitis B
Professor Ulrike Protzer and her TherVacB team at Helmholtz Munich and TUM have been honoured with the prestigious Bavarian m4 Award 2023. Key members of the Helmholtz Munich and TUM team for TherVacB proudly received the m4 Award on 24 October 2023 at Munich...
IP-cure-B & TherVacB researchers join forces to accelerate hepatitis B cure research
Experts in virology, immunology and clinical hepatitis from two research projects are working towards to cure hepatitis B: ‘IP-cure-B – Take care of your health’ and ‘TherVacB - A therapeutic vaccine to cure Hepatitis B’.To jointly tackle some of the major challenges...
Hep Can’t Wait – It’s World Hepatitis Day 2023!
Every year, more than a million lives are lost to hepatitis. The TherVacB team of clinical researchers, hepatologists and virologists is not waiting for change – we’re working hard to make it happen! A better understanding of the hepatitis B infection and the...